MedTrace Logo

Feasibility Study for Fibroblast Autologous Skin Grafts

NCT01964859 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-11-10

No results posted yet for this study

Summary

This research is being done to determine if investigators can change skin from one type to another. Specifically, investigators are interested in making normal skin into the thicker skin found on our palms and soles.

Conditions

  • Wounds and Injuries

Interventions

BIOLOGICAL

autologous skin fibroblasts

autologous skin fibroblasts

BIOLOGICAL

Filler Product

In some select subjects the investigators will test if the addition of an FDA approved filler product Bellafill might enhance cellular efficacy.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • United States Department of Defense

    collaborator FED

  • Maryland Stem Cell Research Fund

    collaborator UNKNOWN

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Luis Garza, MD, PhD · Department of Dermatology, Johns Hopkins School of Medicine

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-07
Primary Completion
2027-12-02
Completion
2028-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964859 on ClinicalTrials.gov